WordPress database error: [Table './shroom/wp_clean_up_optimizer_ip_locations' is marked as crashed and last (automatic?) repair failed]
SELECT * FROM wp_clean_up_optimizer_ip_locations WHERE ip='3.238.250.73'

WordPress database error: [Table './shroom/wp_clean_up_optimizer_ip_locations' is marked as crashed and last (automatic?) repair failed]
SHOW FULL COLUMNS FROM `wp_clean_up_optimizer_ip_locations`

Aion Therapeutic Inc. – Shroom Investor πŸ„

Aion Therapeutic Inc.

Aion Therapeutic Inc.

Financials254 views2 min read

Aion Therapeutic Files Financials

Aion Therapeutic
Toronto, Ontario--(Newsfile Corp. - November 2, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203").Management of... Read More...
134 views2 min read

Aion Therapeutic Provides Default Status Update

Aion Therapeutic
TORONTO, Sept. 14, 2021 /CNW/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). On August 31, 2021, the Company anno... Read More...
370 views2 min read

Aion Therapeutic Provides Notice of Default

Aion Therapeutic
TORONTO, Aug. 31, 2021 - Aion Therapeutic Inc. (CSE: AION)Β ("Aion Therapeutic" or the "Company") announces that it anticipates being late in filing its audited annual financial statements (the "Annual Financial Statements") and related management discussion and analysis ("MD&A") for the year ended April 30, 2021, by the prescribed dea... Read More...
1 views9 min read

Combined Apollon and Aion Formulations Kill Breast Cancer Cells Through Multiple Pathways

Aion Therapeutic
LONDON and TORONTO, May 18, 2021 -Β Apollon Formularies plc (AQSE: APOL)Β ("Apollon" or theΒ "Company"), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, andΒ Aion Therapeutic Inc. (CSE: AION)Β ("Aion"), a BC based international pharmaceutical company trading on the Canadian Securities Exchange,Β are pleased ... Read More...
1 views3 min read

Aion Therapeutic Amends Convertible Debentures

Aion Therapeutic
Toronto, Ontario--(Newsfile Corp. - October 30, 2020) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company has entered into a convertible debenture extension and amendment agreement (the "Amending Agreement") dated October 29, 2020 with Quinsam Capital Corporation (the "Lender"). The A... Read More...
28 views6 min read

Aion Therapeutic, Inc. Announces the Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas as Chief Science Officer

Aion Therapeutic
Dr. Fritsche has also been appointed Chief Science Officer of AI Pharma, a wholly-owned subsidiary of Aion TherapeuticToronto, Ontario--(Newsfile Corp. - September 10, 2020) - Dr. Fritsche is a world-renowned Clinical Chemist and former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!